TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19176272

Group type: EXPERIMENTAL
Intervention: Goserelin and flutamide (STAD) for 3 or 6 months before and during radiation therapy (66 Gy to the prostate and seminal vesicles)
Number of subjects: 802

Group type: COMPARATOR
Intervention: Radiation therapy (XRT) alone
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: Goserelin and flutamide (STAD)
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: Phoenix fail criteria
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: ASTRO fail criteria
Number of subjects: 802
Study: 17255866

Group type: EXPERIMENTAL
Intervention: Debriefing cards/checklists for bedside teaching
Number of subjects: 0
Study: 15500814

Group type: EXPERIMENTAL
Intervention: Cognitive preparation for video feedback
Number of subjects: 95

Group type: COMPARATOR
Intervention: Attention-control preparation
Number of subjects: 95
Study: 12523868

Group type: COMPARATOR
Intervention: Bilateral ECT (N = 11)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: High-charge right unilateral ECT (N = 13)
Number of subjects: 24
Study: 10432873

Group type: EXPERIMENTAL
Intervention: Semiquantitative approach using 10 cytologic criteria rated on a 1-3 scale
Number of subjects: 61
Study: 7640931

Group type: EXPERIMENTAL
Intervention: Quantitative computed tomography (QCT)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Dual X‐ray absorptiometry (DXA)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Spinal QCT
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Total hip DXA
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Ward hip DXA
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Volumetric spinal DXA
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Spinal QCT, total and Ward hip DXA, volumetric spinal DXA
Number of subjects: 112
Study: 2225508

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics continued for at least 48 hours in patients requiring a tracheotomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 105622

Group type: EXPERIMENTAL
Intervention: Type B vitamin combination (5 mg/day thiamin HCl and 3 mg/day pyridoxine HCl)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Type C vitamin combination (5 mg/day thiamin HCl and 3 mg/day pyridoxine HCl)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Type A vitamin combination (55 mg/day thiamin HCl and 102 mg/day pyridoxine HCl)
Number of subjects: 0
Study: 31870766

Group type: EXPERIMENTAL
Intervention: ECAP-controlled closed-loop spinal cord stimulation
Number of subjects: 134

Group type: COMPARATOR
Intervention: Fixed-output, open-loop spinal cord stimulation
Number of subjects: 134
Study: 31270217

Group type: COMPARATOR
Intervention: Right-cathodal tDCS
Number of subjects: 12

Group type: COMPARATOR
Intervention: Left-anodal tDCS
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 12
Study: 28302084

Group type: EXPERIMENTAL
Intervention: EMDR plus treatment as usual (TAU)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Treatment as usual (TAU) alone
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: EMDR plus TAU
Number of subjects: 158

Group type: COMPARATOR
Intervention: TAU alone
Number of subjects: 158
Study: 25988676

Group type: EXPERIMENTAL
Intervention: Rilpivirine (RPV) long-acting formulation, 300 mg
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Rilpivirine (RPV) long-acting formulation, 600 mg
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Rilpivirine (RPV) long-acting formulation, 1200/600/600 mg
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 25159126

Group type: EXPERIMENTAL
Intervention: PREFER (person-centred and integrated Palliative advanced home care and heart Failure care)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: PREFER
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 36
Study: 22067758

Group type: EXPERIMENTAL
Intervention: Doxycycline (40 mg daily)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 19250012

Group type: EXPERIMENTAL
Intervention: Online chat (computer-mediated communication)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Face-to-face communication
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: High trait loneliness (computer-mediated communication)
Number of subjects: 234
Study: 17898169

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IL-13
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 0
Study: 15352602

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 1739

Group type: EXPERIMENTAL
Intervention: Duration of operation longer than 2 hours
Number of subjects: 1739
Study: 11683740

Group type: EXPERIMENTAL
Intervention: Somatostatin-14 (S-14) infusion for 7 days
Number of subjects: 75
Study: 9893697

Group type: EXPERIMENTAL
Intervention: Hormonotherapy and chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Taxans (docetaxel, paclitaxel)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aromatase inhibitors (letrozole, anastrozole)
Number of subjects: 0
Study: 7983288

Group type: EXPERIMENTAL
Intervention: Multimethod educational interventions
Number of subjects: 1140
Study: 2303582

Group type: EXPERIMENTAL
Intervention: ibuprofen 800 mg tablets
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: ibuprofen 800 mg aqueous suspension
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: ibuprofen 800 mg orange juice suspension
Number of subjects: 35

Group type: COMPARATOR
Intervention: 325 mg aspirin tablets
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: ibuprofen suspensions
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: ibuprofen tablets
Number of subjects: 35
Study: 366897

Group type: EXPERIMENTAL
Intervention: Combined drug treatment (vincristin, 5‐fluoruracil, methotrexate, cyclophosphane, prednisolone)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Combined drug treatment plus ovariectomy and continuous administration of prednisolone, testosterone‐propionate or synoestrol
Number of subjects: 70
Study: 31465154

Group type: EXPERIMENTAL
Intervention: Mobil-O-Graph
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Arteriograph
Number of subjects: 211

Group type: COMPARATOR
Intervention: Complior
Number of subjects: 211
Study: 26890930

Group type: EXPERIMENTAL
Intervention: Learning discriminative subspaces using principal component analysis and random contrasts for image saliency analysis.
Number of subjects: 0
Study: 25356603

Group type: EXPERIMENTAL
Intervention: Nilotinib 300 mg bid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dasatinib 100 mg qd
Number of subjects: 0
Study: 23769755

Group type: EXPERIMENTAL
Intervention: 2L polyethylene glycol+ascorbate
Number of subjects: 400

Group type: COMPARATOR
Intervention: 4L polyethylene glycol solution
Number of subjects: 400
Study: 21665011

Group type: EXPERIMENTAL
Intervention: Functional Disorders (FD) diagnosed by psychiatric research interview
Number of subjects: 1785

Group type: EXPERIMENTAL
Intervention: Medically Unexplained Symptoms (MUS) diagnosed by GP
Number of subjects: 1785

Group type: EXPERIMENTAL
Intervention: More than 4 symptoms
Number of subjects: 1785

Group type: EXPERIMENTAL
Intervention: Functional Disorders (FD)
Number of subjects: 1785

Group type: EXPERIMENTAL
Intervention: Medically Unexplained Symptoms (MUS)
Number of subjects: 1785

Group type: COMPARATOR
Intervention: Neither FD nor MUS
Number of subjects: 1785
Study: 18637100

Group type: EXPERIMENTAL
Intervention: Topical estriol
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 17924131

Group type: EXPERIMENTAL
Intervention: 0.15 mg/m3 epsilon-caprolactam vapours
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 5 mg/m3 epsilon-caprolactam vapours
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 0.5 mg/m3 epsilon-caprolactam vapours
Number of subjects: 20

Group type: COMPARATOR
Intervention: 0 mg/m3 epsilon-caprolactam vapours (control)
Number of subjects: 20
Study: 15361119

Group type: EXPERIMENTAL
Intervention: Low socioeconomic class children
Number of subjects: 176

Group type: COMPARATOR
Intervention: High socioeconomic class children
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Children aged <3 years
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Children aged 3-6 years
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Children aged 7-10 years
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Males
Number of subjects: 176

Group type: COMPARATOR
Intervention: Females
Number of subjects: 176
Study: 11595778

Group type: EXPERIMENTAL
Intervention: HRT (17beta estradiol plus cyclic norethisterone acetate)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 9876789

Group type: EXPERIMENTAL
Intervention: Epidural PCA with pethidine
Number of subjects: 25

Group type: COMPARATOR
Intervention: Intravenous PCA with pethidine
Number of subjects: 25
Study: 8023265

Group type: EXPERIMENTAL
Intervention: Clindamycin plus amikacin
Number of subjects: 67

Group type: COMPARATOR
Intervention: Clindamycin plus aztreonam
Number of subjects: 67
Study: 2730824

Group type: EXPERIMENTAL
Intervention: Halothane anaesthesia
Number of subjects: 50

Group type: COMPARATOR
Intervention: Isoflurane anaesthesia
Number of subjects: 50
Study: 4140268

Group type: EXPERIMENTAL
Intervention: Atropine injection
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Selective vagotomy
Number of subjects: 31

Group type: COMPARATOR
Intervention: Truncal vagotomy
Number of subjects: 31

Group type: COMPARATOR
Intervention: Preoperative controls
Number of subjects: 31
Study: 11373164

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle (reduced fat and calorie intake and increased activity)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle plus ongoing formal evaluation for continuous quality improvement
Number of subjects: 23

Group type: COMPARATOR
Intervention: Both interventions (intensive lifestyle and intensive lifestyle plus evaluation)
Number of subjects: 23
Study: 31310895

Group type: EXPERIMENTAL
Intervention: Ostensive labeling events with lexical contrast and/or mutual exclusivity
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Minimal linguistic support ('It's a kind of dog.')
Number of subjects: 52
Study: 30219433

Group type: EXPERIMENTAL
Intervention: Spirulina Platensis (4 x 500 mg daily tablets along with restricted calorie diet)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Spirulina Platensis
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo (placebo tablets along with restricted calorie diet)
Number of subjects: 52
Study: 26886884

Group type: EXPERIMENTAL
Intervention: Physical therapy (PT) for urinary incontinence, 12 weekly sessions
Number of subjects: 48

Group type: COMPARATOR
Intervention: Osteoporosis education (Control)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Physical therapy (PT) for urinary incontinence
Number of subjects: 48
Study: 25260723

Group type: EXPERIMENTAL
Intervention: Bag-mask ventilation
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Supraglottic airway device (SAD)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Tracheal intubation
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Further airway interventions
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Intubation as initial approach
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Bag-mask as initial approach
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: SAD as initial approach
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Reasons for changing from bag-mask
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Reasons for removing a SAD
Number of subjects: 196
Study: 23094941

Group type: EXPERIMENTAL
Intervention: RealFX™ Q‐Plus™ Chews (500 mg quercetin)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: First Strike™ Bars (500 mg quercetin)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Tang(®) suspension (500 mg quercetin)
Number of subjects: 18
Study: 21180009

Group type: EXPERIMENTAL
Intervention: Panavia F 2.0
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Variolink II
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: RelyX U100
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Maxcem
Number of subjects: 192

Group type: COMPARATOR
Intervention: 96% isopropanol cleaning
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Silica coating and silanization
Number of subjects: 192
Study: 17416908

Group type: EXPERIMENTAL
Intervention: Removal of laryngeal tube in anaesthetized state (Group A: 2% sevoflurane)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Removal of laryngeal tube in awake state (Group B)
Number of subjects: 70
Study: 16329364

Group type: EXPERIMENTAL
Intervention: Collamer IOL
Number of subjects: 122

Group type: COMPARATOR
Intervention: AcrySof IOL
Number of subjects: 122

Group type: COMPARATOR
Intervention: Plate haptic silicone IOL
Number of subjects: 122

Group type: COMPARATOR
Intervention: Sensar IOL
Number of subjects: 122
Study: 12485286

Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005% once daily
Number of subjects: 226

Group type: COMPARATOR
Intervention: Dorzolamide 2% and timolol 0.5% fixed combination twice daily
Number of subjects: 226
Study: 9807532

Group type: EXPERIMENTAL
Intervention: Community organization approach to promote nonsmoking
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (untreated neighborhoods in Kansas City)
Number of subjects: 0
Study: 7550011

Group type: EXPERIMENTAL
Intervention: Simulated Public Speaking (SPS)
Number of subjects: 524

Group type: EXPERIMENTAL
Intervention: Stroop Color Word Test (SCWT)
Number of subjects: 524
Study: 2479177

Group type: EXPERIMENTAL
Intervention: Resection (including total gastrectomy in 64 patients)
Number of subjects: 503

Group type: COMPARATOR
Intervention: Nonresectional treatment (including bypass and exploratory laparotomy)
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: Resection
Number of subjects: 503

Group type: COMPARATOR
Intervention: Nonresectional procedure
Number of subjects: 503
Study: 1190701

Group type: EXPERIMENTAL
Intervention: Osmic acid
Number of subjects: 123

Group type: COMPARATOR
Intervention: Hydrocortisone acetate
Number of subjects: 123

Group type: COMPARATOR
Intervention: Methylprednisolone acetate
Number of subjects: 123
Study: 30317548

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (20,000 IU weekly)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study: 27921860

Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Therapy (CRT)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control (historical group)
Number of subjects: 33
Study: 25766269

Group type: EXPERIMENTAL
Intervention: CaCBT plus Treatment As Usual (TAU)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Treatment As Usual (TAU)
Number of subjects: 137
Study: 24320193

Group type: EXPERIMENTAL
Intervention: Shared care combined with telecare
Number of subjects: 95

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 95
Study: 22634448

Group type: EXPERIMENTAL
Intervention: PHiD-CV co-administered with DTPw-HBV/Hib
Number of subjects: 360

Group type: COMPARATOR
Intervention: Hib vaccine co-administered with DTPw-HBV (Control)
Number of subjects: 360
Study: 19579592

Group type: EXPERIMENTAL
Intervention: IFN‐beta‐1a
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: IFN‐beta‐1a plus ribavirin (RBV)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Combination therapy or normal ALT on 48w
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Post-treatment biopsies
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: HAI, alpha‐SMA, collagen type III values
Number of subjects: 21
Study: 17578385

Group type: EXPERIMENTAL
Intervention: Sibutramine treatment
Number of subjects: 0
Study: 15126574

Group type: EXPERIMENTAL
Intervention: Pyridostigmine (PD, 120 mg per os)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Pirenzepine (PZ, 100 mg per os)
Number of subjects: 6
Study: 12092646

Group type: EXPERIMENTAL
Intervention: Ondansetron (8 mg intravenously)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Diclofenac sodium (75 mg intramuscularly)
Number of subjects: 64
Study: 10322874

Group type: EXPERIMENTAL
Intervention: Qumotang (QMT)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 214
Study: 8134155

Group type: EXPERIMENTAL
Intervention: 2.5 and 5.0 mg prednisolone
Number of subjects: 25

Group type: COMPARATOR
Intervention: 200 and 800 micrograms inhaled budesonide
Number of subjects: 25
Study: 3298294

Group type: EXPERIMENTAL
Intervention: Surgical procedures (not specified)
Number of subjects: 0
Study: 29868821

Group type: EXPERIMENTAL
Intervention: Vanilla odor (food-associated)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Rose odor (not food-associated)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo (no odor)
Number of subjects: 150
Study: 28407162

Group type: EXPERIMENTAL
Intervention: Topical ketorolac preoperatively
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control (no NSAID pretreatment)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Topical ketorolac
Number of subjects: 42
Study: 26204202

Group type: EXPERIMENTAL
Intervention: 555 MBq (15 mCi) of I
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: 1110 MBq (30 mCi) of I
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Doses greater than 300 Gy
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Doses less than 300 Gy
Number of subjects: 91
Study: 24116747

Group type: EXPERIMENTAL
Intervention: Oesophageal Doppler monitor group (51 patients)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (50 patients)
Number of subjects: 102
Study: 20854699

Group type: EXPERIMENTAL
Intervention: Fortified soya milk
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fermented and fortified soya milk
Number of subjects: 12
Study: 19058685

Group type: EXPERIMENTAL
Intervention: Panavia F 2.0 (Kuraray, PF) with method M
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Panavia F 2.0 (Kuraray, PF) with method NO‐M
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: MultiCore Flow (Ivoclar Vivadent, MF) with method M
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: MultiCore Flow (Ivoclar Vivadent, MF) with method NO‐M
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Panavia F 2.0 (Kuraray, PF) with method M (GC)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Panavia F 2.0 (Kuraray, PF) with method NO‐M (GC)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: MultiCore Flow (Ivoclar Vivadent, MF) with method M (GC)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: MultiCore Flow (Ivoclar Vivadent, MF) with method NO‐M (GC)
Number of subjects: 44
Study: 16832078

Group type: EXPERIMENTAL
Intervention: Memantine (20 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12716320

Group type: EXPERIMENTAL
Intervention: Vaginal hysterectomy
Number of subjects: 36
Study: 11064385

Group type: EXPERIMENTAL
Intervention: Postoperative radiation therapy (RT)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Combined RT and chemotherapy (5-FU plus levamisole)
Number of subjects: 218
Study: 9057069

Group type: EXPERIMENTAL
Intervention: Captopril (first dose 2-4 hours after starting thrombolysis, increased up to 25 mg every 8 hours)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 45
Study: 8314468

Group type: EXPERIMENTAL
Intervention: Interferon alfa‐2b (5 million units, three times weekly)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (n = 10)
Number of subjects: 25
Study: 3470319

Group type: EXPERIMENTAL
Intervention: Test dentifrice containing 1% zinc citrate and 0.5% Triclosan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29653636

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan (titrated to 97/103 mg by mouth twice daily for 8 weeks, followed by open-label treatment for 4 weeks)
Number of subjects: 882

Group type: COMPARATOR
Intervention: Enalapril (titrated to 10 mg by mouth twice daily for 8 weeks)
Number of subjects: 882

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 882

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 882
Study: 27196650

Group type: EXPERIMENTAL
Intervention: Mailing a short paper survey with a prepaid incentive ($2 coin)
Number of subjects: 8000

Group type: EXPERIMENTAL
Intervention: Survey mode (paper vs online)
Number of subjects: 8000

Group type: COMPARATOR
Intervention: Sampling frame (InfoCanada vs Canada Post)
Number of subjects: 8000

Group type: EXPERIMENTAL
Intervention: Questionnaire length (10 minutes vs 30 minutes)
Number of subjects: 8000

Group type: EXPERIMENTAL
Intervention: Prepaid incentive ($2 coin vs none)
Number of subjects: 8000

Group type: EXPERIMENTAL
Intervention: Lottery incentive (instant vs end‐of‐study)
Number of subjects: 8000
Study: 24238783

Group type: EXPERIMENTAL
Intervention: Go/NoGo task with event-related potentials (ERPs)
Number of subjects: 89
Study: 22074724

Group type: EXPERIMENTAL
Intervention: Intravenous glulisine insulin using a paper-based glucose-lowering algorithm followed by once-daily subcutaneous insulin glargine for 30 days
Number of subjects: 287

Group type: COMPARATOR
Intervention: Standard glycemic approaches
Number of subjects: 287
Study: 20466334

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine-lidocaine-propofol (1 mg/kg dexmedetomidine)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fentanyl-lidocaine-propofol (2 mg/kg fentanyl)
Number of subjects: 60
Study: 18661125

Group type: EXPERIMENTAL
Intervention: Varenicline 1 mg BID with digoxin (Lanoxicaps 0.2 mg QD)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo with digoxin (Lanoxicaps 0.2 mg QD)
Number of subjects: 18
Study: 15819504

Group type: EXPERIMENTAL
Intervention: Statin treatment
Number of subjects: 1136

Group type: COMPARATOR
Intervention: Control (no statin treatment)
Number of subjects: 1136

Group type: COMPARATOR
Intervention: Overall (Statin vs Control)
Number of subjects: 1136
Study: 11331318

Group type: EXPERIMENTAL
Intervention: Intensive combination chemotherapy without local radiation therapy
Number of subjects: 30